SB 433 — 'Diabetes Drug Pricing Transparency Act of 2020'; disclosure of diabetes prescription drug pricing; require
Last action — Senate Read and Referred
-
✓Introduced
-
2In Committee
-
3Passed Senate
-
4Passed House
-
5To Executive
-
6Enacted
This bill died with 2019-2020 Regular Session. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
This bill is no longer active — its legislative session has ended, so there is no live prognosis. It would have to be reintroduced in the current session to move again.
Summary
A BILL to be entitled an Act to amend Title 33 of the Official Code of Georgia Annotated, relating to insurance, so as to require disclosure of diabetes prescription drug pricing; to provide for a short title; to provide for legislative findings; to provide for definitions; to provide for a listing of diabetes prescription drugs; to provide for drug manufacturer and pharmacy benefits manager report forms and insurer pricing reports; to provide for certain other reports; to provide for penalties; to amend Chapter 1 of Title 10 of the Official Code of Georgia Annotated, relating to selling and other trade practices, so as to provide for penalties regarding unfair or deceptive practices in consumer transactions; to provide for related matters; to provide for an effective date and applicability; to repeal conflicting laws; and for other purposes.
Bill Text
We don't have the full text on file for this bill yet.
Read SB 433 on the official Georgia source →Action History
-
Senate Read and Referred
-
Senate Hopper
Sponsors
- Burt Jones · Primary
- Lee Anderson · Primary
- Dean Burke · Primary
- P. K. Martin IV · Primary
- Matt Brass · Primary
Sponsorship breakdown
Export CSV (upgrade) →5 sponsors · 0 co-sponsors · 242 not signed on
Sponsors (5)
- Burt Jones
- Lee Anderson Republican
- Dean Burke
- P. K. Martin IV
- Matt Brass Republican
Co-sponsors (0)
None.
Not signed on (242)
242 members have not signed on to this bill.
Show all 242 →"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.
Subjects
Frequently asked questions
- What does SB 433 do?
- A BILL to be entitled an Act to amend Title 33 of the Official Code of Georgia Annotated, relating to insurance, so as to require disclosure of diabetes prescription drug pricing; to provide for a short title; to provide for legislative findings; to provide for definitions; to provide for a listing of diabetes prescription drugs; to provide for drug manufacturer and pharmacy benefits manager report forms and insurer pricing reports; to provide for certain other reports; to provide for penalties; to amend Chapter 1 of Title 10 of the Official Code of Georgia Annotated, relating to selling and other trade practices, so as to provide for penalties regarding unfair or deceptive practices in consumer transactions; to provide for related matters; to provide for an effective date and applicability; to repeal conflicting laws; and for other purposes.
- Who sponsors SB 433?
- SB 433 is sponsored by Burt Jones, Lee Anderson (Republican), Dean Burke, P. K. Martin IV, and Matt Brass (Republican).
- What is the current status of SB 433?
- This bill died with 2019-2020 Regular Session. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
- Where can I track SB 433?
- Track SB 433 free on One Click Politics — get push/email alerts when it moves.
Make your voice heard on SB 433
Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.
Stay ahead of SB 433
Last checked for changes 3 months ago · updated continuously
One Click Politics tracks every bill in Congress and all 50 states.
Track this bill →